Skip to main content
. 2020 Oct 28;10:130. doi: 10.1186/s13550-020-00709-y

Fig. 3.

Fig. 3

Plot showing the temporal relationship of the median value of visual analogue score (VAS) of patients from baseline up to 16 weeks of post-[177Lu]Lu-DOTA-ZOL therapy